DNA 신시사이저 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 기술별, 용도별, 최종사용자별, 규모별, 자동화 레벨별, 지역별 - 업계 예측(2026-2033년)

Global Dna Synthesizer Market size was valued at USD 680.00 Million in 2024 and is poised to grow from USD 780.00 Million in 2025 to USD 2230.00 Million by 2033, growing at a CAGR of 14.1% during the forecast period (2026-2033).

The global DNA synthesizer market is driven by surging demand for custom oligonucleotides and synthetic genes, fostering innovations in biotechnology. This market encompasses instruments and reagents essential for automating de novo DNA synthesis, empowering researchers in areas ranging from fundamental studies to therapeutic and industrial applications. The platform facilitates gene editing, vaccine production, and synthetic DNA bio-manufacturing, thereby accelerating project timelines and reducing costs. Over time, the evolution from manual synthesis to high-throughput synthesizers and cloud-based ordering has increased industry capacity. Enhanced error correction in new synthesizers is elevating demand from pharmaceutical developers and CMOs for longer nucleotide sequences, essential for gene therapy and vaccine prototyping. This growth is attracting investor funding for capacity expansion and automated workflows, while academic labs increasingly adopt in-house DNA synthesis capabilities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dna Synthesizer market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Dna Synthesizer Market Segments Analysis

Global dna synthesizer market is segmented by product type, technology, application, end user, scale, automation level and region. Based on product type, the market is segmented into benchtop DNA synthesizers, high-throughput DNA synthesizers, portable DNA synthesizers and others. Based on technology, the market is segmented into phosphoramidite synthesis, microarray-based synthesis and enzymatic DNA synthesis. Based on application, the market is segmented into synthetic biology, gene synthesis, PCR primer synthesis, DNA sequencing, drug discovery and others. Based on end user, the market is segmented into biotechnology companies, pharmaceutical companies, academic & research institutes, contract research organizations (CROs) and diagnostic laboratories. Based on scale, the market is segmented into research scale and commercial scale. Based on automation level, the market is segmented into fully automated and semi-automated. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Driver of the Global Dna Synthesizer Market

The Global DNA Synthesizer market is experiencing growth driven by advancements in automated workflows and integrated synthesis technologies, which minimize the need for manual intervention while enhancing throughput consistency. This simplification has significantly reduced the complexities associated with operating DNA synthesizers, allowing personnel with varying levels of expertise to use these devices with reliability. As a result, there is a growing opportunity for new users to incorporate DNA synthesizers in settings beyond specialized laboratories. By facilitating easier operations and standardizing synthesis processes, the research and industrial sectors are motivated to invest more in DNA synthesizers, thereby expanding their applications worldwide.

Restraints in the Global Dna Synthesizer Market

The global DNA synthesizer market faces significant restraints primarily due to the high costs associated with the acquisition and maintenance of advanced equipment. Small academic laboratories and emerging startups, often operating on tight budgets, are deterred from utilizing these sophisticated synthesizers due to their expense, including consumables and the need for periodic calibrations. Consequently, many organizations opt to collaborate with third-party providers instead of developing in-house capabilities, which hampers the introduction of new technologies into the market. Additionally, the substantial cost of ownership compels buyers to seek substantial returns on their investments, leading to longer procurement processes and reduced enthusiasm for acquiring new models.

Market Trends of the Global Dna Synthesizer Market

The Global DNA Synthesizer market is witnessing a significant trend towards platform integration, which is enhancing accessibility for a broader range of users, including life sciences researchers, small biotech firms, and clinical service providers. By consolidating various synthesis processes into user-friendly applications, the industry is lowering technical barriers through standardized reagent interfaces, modular hardware, and intuitive software systems. This shift enables entities without extensive specialized infrastructure to leverage gene synthesis capabilities, facilitating quicker experimental development and collaborative sharing. The growing emphasis on ease-of-use, interoperability, and robust service delivery is reshaping research and therapeutic discovery, thereby driving market expansion and innovation.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Case Studies
• Technology Assessment
• Customer & Buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology

Global DNA Synthesizer Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Benchtop DNA Synthesizers
• High-Throughput DNA Synthesizers
• Portable DNA Synthesizers
• Others

Global DNA Synthesizer Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Phosphoramidite Synthesis
• Microarray-Based Synthesis
• Enzymatic DNA Synthesis

Global DNA Synthesizer Market Size by Application & CAGR (2026-2033)

• Market Overview
• Synthetic Biology
• Gene Synthesis
• PCR Primer Synthesis
• DNA Sequencing
• Drug Discovery
• Others

Global DNA Synthesizer Market Size by End User & CAGR (2026-2033)

• Market Overview
• Biotechnology Companies
• Pharmaceutical Companies
• Academic & Research Institutes
• Contract Research Organizations (CROs)
• Diagnostic Laboratories

Global DNA Synthesizer Market Size by Scale & CAGR (2026-2033)

• Market Overview
• Research Scale
• Commercial Scale

Global DNA Synthesizer Market Size by Automation Level & CAGR (2026-2033)

• Market Overview
• Fully Automated
• Semi-Automated

Global DNA Synthesizer Market Size & CAGR (2026-2033)

• North America (Product Type, Technology, Application, End User, Scale, Automation Level)
  • US
  • Canada
• Europe (Product Type, Technology, Application, End User, Scale, Automation Level)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, Application, End User, Scale, Automation Level)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, Application, End User, Scale, Automation Level)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, Application, End User, Scale, Automation Level)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioAutomation Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DNA Script
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twist Bioscience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Codex DNA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kilobaser
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synbio Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioneer Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LGC Biosearch Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• K&A Labs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hongene Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated DNA Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CEM Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biolytic Lab Performance
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Polygen GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nitto Denko Avecia
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations